Interlationship between psychology and cytokines

Journal of Biological Regulators and Homeostatic Agents

Volumn 24, Issue 4, 2010, Pages 485-490

  Conti, C M ^a   Fulcheri, M ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cytokines; Immune system; Stress

Indexed keywords

ALPHA INTERFERON; CYCLIC AMP; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 6; PROSTAGLANDIN E2; SEROTONIN TRANSPORTER; SUBSTANCE P; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANXIETY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; CENTRAL NERVOUS SYSTEM; CHRONIC STRESS; COGNITIVE DEFECT; CYTOKINE PRODUCTION; DEPRESSION; DISEASE EXACERBATION; DNA POLYMORPHISM; ENDOCRINE SYSTEM; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; MEMBRANE PERMEABILITY; METABOLIC SYNDROME X; MOOD DISORDER; NEUROTRANSMISSION; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PSORIASIS; PSYCHOLOGY; RHEUMATOID ARTHRITIS; RISK FACTOR; SCHIZOPHRENIA; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; VIRUS INFECTION; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; MENTAL DISEASE; PHYSIOLOGICAL STRESS; REVIEW; SIGNAL TRANSDUCTION;

CYTOKINES; HUMANS; INFLAMMATION; MENTAL DISORDERS; NEUROIMMUNOMODULATION; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 79952277344     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Figueiredo-Braga M, Mota-Garcia F, O'Connor JE, Garcia JR, Mota-Cardoso R, Cardoso CS, De Sousa M. Cytokines and anxiety in systemic lupus erythematosus (SLE) patients not receiving antidepressant medication: a little-explored frontier and some of its brief history. Ann N Y Acad Sci 2009; 1173:286-91.
2. Goshen I, Yirmiya R. Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 2009; 30:30-45.
3. Eller LS. Depressive symptoms in HIV disease. Nurs Clin North Am 2006; 41:437-53. (Pubitemid 44189976)
4. Myers JS, Pierce J, Pazdernik T. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment. Oncol Nurs Forum 2008; 35:916-20.
5. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 2009; 34:4-20.
6. Carlo-Stella N, Bozzini S, De Silvestri A, Sbarsi I, Pizzochero C, Lorusso L, Martinetti M, Cuccia M. Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome. Int J Immunopathol Pharmacol 2009; 22:745-54.
7. Pietrangelo T, Mancinelli R, Toniolo L, Montanari G, Vecchiet J, Fanò G, Fulle S. Transcription profile analysis of Vastus lateralis muscle from patients with chronic fatigue syndrome. Int J Immunopathol Pharmacol 2009; 22:795-807.
8. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 2008; 29:287-91.
9. Karapanou V, Kempuraj D, Theoharides TC. Oral neuroimmune network and mast cells. Eur J Inflamm 2009; 7:1-8.
10. Galliera E, Locati M, Mantovani A, Corsi MM. Chemokine system: new inflammatory markers on the horizon. Eur J Inflamm 2010; 8:1-6.
11. Castellani ML, Felaco P, Pandolfi F, et al. Inflammatory compounds: neuropeptide substance P and cytokines. Eur J Inflamm 2009; 7:63-70.
12. Schubert C, Schüssler G. Psychoneuroimmunology: an update. Z Psychosom Med Psychother 2009; 55:3-26.
13. Nishimura Y, Maeda M, Kumagai N, Hayashi H, Miura Y, Otsuki T. Decrease in phosphorylation of ERK following decreased expression of NK cell activating receptors in human NK cell line exposed to asbestos. Int J Immunopathol Pharmacol 2009; 22:879-88.
14. Murdaca G, Colombo BM, Puppo F. Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol 2009; 22:557-65.
15. Larosa M, Ciprandi G, Tesi CF, Cadario G, Fiocchi A, Frati F, Romano A. Specific immunotherapy for allergic rhinitis in Italy: the patients' points of view. Int J Immunopathol Pharmacol 2009; 22:247-50.
16. Szkodzinski J, Blazelonis A, Wilczek K, et al. The role of interleukin-6 and transforming growth factor-β1 in predicting restenosis within stented infarct-related artery. Int J Immunopathol Pharmacol 2009; 22:493-500.
17. Hurlock EC 4th. Interferons: potential roles in affect. Med Hypotheses 2001; 56:558-66.
18. Rollino C, Massara C, Besso L, et al. Carotid intima-media thickness and anti-phospholipid antibodies in patients with systemic lupus erythematosus. Eur J Inflamm 2009; 7:19-24.
19. Figueiredo-Braga M, Mota-Garcia F, O'Connor JE, Garcia JR, Mota-Cardoso R, Cardoso CS, De Sousa M. Cytokines and anxiety in systemic lupus erythematosus (SLE) patients not receiving antidepressant medication: a little-explored frontier and some of its brief history. Ann NY Acad Sci 2009; 1173:286-91.
20. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9:46-56. (Pubitemid 350295688)
21. Cencioni MT, Notturno F, Caporale CM, Creati B, Prencipe V, Battistini L, Uncini A. T cell response in acute motor axonal neuropathy. Int J Immunopathol Pharmacol 2009; 22:1043-50.
22. Zampetti A, Mastrofrancesco A, Flori E, Maresca V, Picardo M, Amerio P, Feliciani C. Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis. Int J Immunopathol Pharmacol 2009; 22:1067-75
23. Soczynska JK, Kennedy SH, Goldstein BI, Lachowski A, Woldeyohannes HO, McIntyre RS. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression? Neurotoxicology 2009; 30:497-521.
24. Craddock D, Thomas A. Cytokines and late-life depression. Essent Psychopharmacol 2006; 7:42-52.
25. Mayr FB, Spiel AO, Leitner JM, Firbas C, Schnee J, Hubert J, Derendorf H, Jilma B. Influence of the duffy antigen on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1, CCL-2) in vivo. Int J Immunopathol Pharmacol 2009; 22:615-625.
26. Janssen DG, Caniato RN, Verster JC, Baune BT. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol 2010; 25:201-15.
27. Miüller N, Schwarz MJ. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm Suppl 2007; 72:269-80.
28. Frezza D, Giambra V, Mattioli C, Piccoli K, Massoud R, Siracusano A, Di Giannantonio M, Birshtein BK, Rubino IA. Allelic frequencies of 3′ Ig heavy chain locus enhancer HS1, 2-A associated with Ig levels in patients with schizophrenia. Int J Immunopathol Pharmacol 2009; 22:115-23.
29. Ardizzone S, Cassinotti A, Trabattoni D, et al. Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol 2009; 22:63-71.
30. Castellani ML, Conti CM, Kempuraj DJ, et al. Autism and immunity: revisited study. Int J Immunopathol Pharmacol 2009; 22:15-19.
31. Theoharides TC. Autism spectrum disorders and mastocytosis. Int J Immunopathol Pharmacol 2009; 22: 859-65.
32. Shuvy M, BenYa'acov A, Zolotarov L, Lotan C, Ilan Y. Beta glycosphingolipids suppress rank expression and inhibit natural killer T cell and CD8+ accumulation in alleviating aortic valve calcification. Int J Immunopathol Pharmacol 2009; 22:911-18.
33. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71:171-86.
34. Johnstone SE, Baylin SB. Stress and the epigenetic landscape: a link to the pathobiology of human diseases? Nat Rev Genet 2010; 11:806-12.
35. Li Q, Kobayashi M, Wakayama Y, et al. Effect of phytoncide from trees on human natural killer cell function. Int J Immunopathol Pharmacol 2009; 22:951-9.
36. Landercasper J, Linebarger JH, Ellis RL, Mathiason MA, Johnson JM, Marcou KA, De Maiffe BM, Jago GS. A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg 2010; 210:449-55.
37. Clauss M, Schaper W. Vascular endothelial growth factor: A Jack-of-all-trades or a nonspecific stress gene? Circ Res 2000; 86:251-2. (Pubitemid 30108815)
38. Mennini T, Giordano L, Mengozzi M, Ghezzi P, Tonelli R, Mantegazza R, Silani V, Corbo M, Lunetta C, Beghi E. Increased IL-8 levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Inflamm 2009; 7:39-44.
39. Harvima IT, Nilsson G, Naukkarinen A. Role of mast cells and sensory nerves in skin inflammation. G Ital Dermatol Venereol 2010; 145:195-204.
40. Nordlind K, Azmitia EC, Slominski A. The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp Dermatol 2008; 17:301-11. (Pubitemid 351338673)
41. Shariati GH, Ahangari G, Asadi MR, Poyafard F, Ahmadkhaniha HR: Dopamine receptor gene expression changes in peripheral blood mononuclear cells from schizophrenic patients treated with haloperidol and olanzapine. Eur J Inflamm 2009; 7:71-76.
42. Harvima IT, Nilsson G, Naukkarinen A. Role of mast cells and sensory nerves in skin inflammation. G Ital Dermatol Venereol 2010; 145:195-204.
43. Caroselli C, Perfetti P, Bruno G. High serum tryptase value in massive acute myocardial infarction with ventricular arrhythmia exortion in a cocaine abuser. Int J Immunopathol Pharmacol 2009; 22:525-9.
44. Herberth G, Daegelmann C, Weber A, et al: LISAplus Study Group. Association of neuropeptides with Th1/Th2 balance and allergic sensitization in children. Clin Exp Allergy 2006; 36:1408-16. (Pubitemid 44674125)
45. Sun J, Ramnath RD, Zhi L, Tamizhselvi R, Bhatia M. Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways. Am J Physiol Cell Physiol 2008; 294:C1586-96.
46. Seybold VS. The role of peptides in central sensitization. Handb Exp Pharmacol 2009; 194:451-91.
47. Castanon-Cervantes O, Wu M, Ehlen JC, et al. Dysregulation of inflammatory responses by chronic circadian disruption. J Immunol 2010; 185:5796-805.